JP1725411S - Inspection equipment - Google Patents

Inspection equipment

Info

Publication number
JP1725411S
JP1725411S JP2021502731F JP2021502731F JP1725411S JP 1725411 S JP1725411 S JP 1725411S JP 2021502731 F JP2021502731 F JP 2021502731F JP 2021502731 F JP2021502731 F JP 2021502731F JP 1725411 S JP1725411 S JP 1725411S
Authority
JP
Japan
Prior art keywords
inspection equipment
patient
checking apparatus
check
inspection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021502731F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of JP1725411S publication Critical patent/JP1725411S/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

This cheking apparatus is to check patient status, i.e. patient monitor.This checking apparatus is to check patient status, i. e. patient monitor.

JP2021502731F 2021-03-23 2021-09-18 Inspection equipment Active JP1725411S (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EM84716840001 2021-03-23

Publications (1)

Publication Number Publication Date
JP1725411S true JP1725411S (en) 2022-09-21

Family

ID=83318494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021502731F Active JP1725411S (en) 2021-03-23 2021-09-18 Inspection equipment

Country Status (1)

Country Link
JP (1) JP1725411S (en)

Similar Documents

Publication Publication Date Title
ES2721501T3 (en) Apparatus for diagnosing failures for smoking devices that are operated electrically
CL2017001797A1 (en) Method and apparatus for measuring autonomous function for the diagnosis and validation of treatments and patient outcomes
MX2019004931A (en) Bisymmetric comparison of sub-epidermal moisture values.
BR112017005444A2 (en) benzyl substituted indazoles as bub1 inhibitors.
SA517390218B1 (en) Apparatus and Methods for Determining Damaged Tissue Using Sub-Epidermal Moisture Measurements
BR112017006663A2 (en) infrasonic stethoscope to monitor physiological processes
BR112019003171A2 (en) methods and apparatus for beam information for independent links
GB2535034A (en) Methods and systems for microbiome characterization, monitoring and treatment
CO7160094A2 (en) System, method and device for electronic patient care
BR112015009109A2 (en) device, system and process for monitoring, information display and control of fluid management medical devices
BR112017008908A2 (en) imaging methods and apparatus for performing shear wave elastography imaging
BR112015025407A2 (en) method and device for testing a transformer
BR112017022618A2 (en) correlation and combination of mdt and qoe metrics
BR112015015024A8 (en) ELECTRONIC PATIENT MONITORING SYSTEM AND CLIENT MONITORING MODULE
BR112017014921A2 (en) transformer testing device and method for testing a transformer
BR112013016128A2 (en) "Method and verification system for applying a set of health care practices"
MX2019003828A (en) Medical fluid therapy machine including servicing regime therefore.
MY165689A (en) Osteotomy below the tibial tuberosity by multiple drilling
CO2018004573A2 (en) Phenyl derivatives as cannabinoid receptor 2 agonists
CL2020001936A1 (en) Methods for the treatment of spinal muscular atrophy.
MX2020012800A (en) Cannabinoids and uses thereof.
BR112021019081A2 (en) Method performed by a wireless device and wireless device for configured trigger test minimization report, method performed by a network node and network node for configured trigger test minimization
EA201790444A1 (en) HSP90-directed visualization and inflammation therapy and infection
BR112017006315A2 (en) therapeutic agent, use of a therapeutic agent, in vitro methods for determining whether a subject with melanoma has a higher risk of metastasis, determining a treatment regimen for a subject suffering from melanoma, treating a subject suffering from melanoma, in vitro test to predict increased risk of metastasis and kits
BR112017011026A2 (en) analytical methods and arrangements for use therein